![]() |
![]() |
|
|
Forward to a colleague |
||
Access Full Stories Microarray expert Affymetrix is to buy molecular biology reagent firm USB Corporation for $75m (€52m) in a bid to accelerate the development of new genetic analysis tools... Read Mapping the 'human embryome' in BioTime BioTimes' subsidiary, Embryome Sciences, is planning to build a relational database that will help identify the hundreds of cell types that can be made from human and mouse embryonic stem cells... Read Industry news in brief - week 51 LabTechnologist.com brings you a round up of recent industry news, with developments at Agilent, Bruker BioSpin, EMD Chemicals, Gene Logic, Paraytec and Thermo Fisher Scientific... Read Harvard Bioscience knocks back Skystone takeover bid Harvard Bioscience has rejected an unsolicited acquisition offer from Skystone Advisors to acquire all outstanding shares of common stock in the life science tools and instrument manufacturer... Read Curiox' mini-bioassay tech to aid cheaper drug development Curiox Biosystems has developed a miniaturisation platform that enables cheaper and more efficient bioassays to be conducted, potentially slashing the costs of life science and drug discovery research... Read |
|||||||||||||||||
All News Headlines for: December | November | October |
|||||||||||||||||
|
Related Industry News William Ransom & Son's future profitability questionable UK-based William Ransom & Son has a shaky future ahead following a disappointing and unacceptable six-month financial report, compounded by a suspension of the companys manufacturing license... Read Pfizer buys CovX to bulk biologics pipeline Pfizer, the world's largest pharma firm, has reached into its pockets to buy CovX, a privately-held US biotech that specialises in combining the strengths of peptides and antibodies into new drugs... Read Preclinical services news in brief In this week's review of activity within the preclinical research services arena, news has emerged involving Ocimum Biosolutions, ChemDiv and MIR Preclinical Services... Read Merck inks multi-million dollar deal with Cognizant Merck & Co. has just inked "multi-million dollar" deal with Cognizant, at a time when the US-based IT services firm is pursuing a greater presence in the life sciences sector... Read
|
|||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@LabTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||